| Baisley K., Kemp T.J., Kreimer A.R., Basu P., Changalucha J., Hildesheim A., Porras C., Whitworth H., Herrero R., Lacey C.J., Schiller J.T., Lucas E., Mutani P., Dillner J., Indangasi J., Muwonge R., Hayes R.J., Pinto L.A., Watson-Jones D. Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial. Lancet Glob Health. 2022 Oct;10(10):e1485-e1493. PMID: 36113532 |
| Mosquera I., Ilbawi A., Muwonge R., Basu P., Carvalho A.L. Cancer burden and status of cancer control measures in fragile states: a comparative analysis of 31 countries. Lancet Glob Health. 2022 Oct;10(10):e1443-e1452. PMID: 36113529 |
| Prudden H.J., Achilles S.L., Schocken C., Broutet N., Canfell K., Akaba H., Basu P., Bhatla N., Chirenje Z.M., Delany-Moretlwe S., Denny L., Gamage D.G., Herrero R., Hutubessy R., Villa L.L., Murillo R., Schiller J.T., Stanley M., Temmerman M., Zhao F., Ogilvie G., Kaslow D.C., Dull P., Gottlieb S.L.; Therapeutic HPV Vaccine PPC Expert Consultation Group*. Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022. Vaccine. 2022 Sep 29;40(41):5843-5855. PMID: 36008233 |